Unique design features have established Abbott mechanical heart valves—including the Regent™ and Masters Series—as a gold standard for reliability and performance, while maintaining low complication rates over the long term.
CONFIDENTLY IMPLANT THE MOST TRUSTED AORTIC MECHANICAL VALVES IN THE WORLD
FIND OUT MORE:
Abbott mechanical heart valves lead the way with a proven bileaflet design that results in low thrombogenicity and excellent patient outcomes.
- Leaflets open to an 85-degree angle in systole due to their upstream positioning, enabled by unique pivot guards (shown at right)
- Strong, uniform velocities within hinge recesses aid washout of blood elements3
- Low carbon surface area means less thrombus formation
- Orifice-to-annulus ratio (as high as 84%) ensures large effective orifice areas (EOAs) and reduces prosthesis-patient mismatch4
THE PIVOT GUARD DESIGN | AN ABBOTT HALLMARK
Featured in all Abbott Mechanical Heart Valves, the Pivot Guard offers benefits both during implant and post-implant
- Recessed design minimizes interaction with sub-annular native mitral valve apparatus
- Minimized carbon surface area can lessen thrombus formation
- Pivot guards help shield pivot mechanism from pannus in growth
- Enables a consistent 85-degree opening angle, promoting minimized leaflet flutter and more laminar flow through the orifice5
LOW THROMBOGENICITY | A NECESSITY IN MHV REPLACEMENTS
Designed with Low Thrombogenicity at the Forefront
- Large internal diameters up to 26.1 mm available promote low pressure gradients6
- Low gradients can help minimize shear stress and thrombogenicity7
- Uniform velocities within hinge recesses help aid washout of blood elements3
- Abbott hinge design enables complete leaflet sweep, further aiding washout
- Abbott hinge design enables complete leaflet sweep, further aiding washout
TV
TV
- Internal Sales Tracking Spreadsheet. Data on file at Abbott.
- MHV Paper List. Data on file at Abbott.
- Jun BH, Saikrishnan N, Yoganathan AP. Micro particle image velocimetry measurements of steady diastolic leakage flow in the hinge of a St. Jude Medical Regent™ mechanical heart valve. Ann Biomed Eng. 2014;42(3):526-540. Published online 2013 Oct 2.doi: 10.1007/s10439-013- 0919-y
- Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol. 2000;36(4):1131-1141. doi.org/10.1016/s0735-1097(00)00859-7
- Shipkowitz T, Ambrus J, Kurk J, et al. Evaluation technique for bileaflet mechanical valves. J Heart Valve Dis. 2002;11(2):275-282.
- Internal Design Prints. Data on file at Abbott.
- Alemu Y, Bluestein D. Flow induced platelet activation and damage accumulation in a mechanical heart valve: numerical studies. Artif Organs. 2007;31(9):677-688. doi: 10.1111/j.1525-1594.2007.00446.x.
- Gammie JS, Chikwe J, Badhwar V, et al. Isolated mitral valve surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database analysis. Ann Thorac Surg. 2018;106(3):716-727.
- Satter Y, Rauf H, Bareeqa S, et al. Transcatheter aortic valve replacement versus surgical aortic valve replacement: A review of aortic stenosis management. Cureus. 2019;11(12):e6431. doi: 10.7759/cureus.6431
- Nishimura RA. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;136(9):1-123.
- Ren X. Aortic stenosis. Medscape. emedicine.medscape.com/article/150638-overview. Updated May 7, 2019.
- Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: A community cohort study. Lancet. 2018;391(10124): 960-969.
- Regent Instructions for Use.
- Regent PMA Supplement.
- Okamura H, Yamaguchi A, Morita H, et al. Is the threshold for postoperative prosthesis-patient mismatch the same for all prostheses? Surg Today. 2013;43:871-876.
- Masters Series Instructions for Use.
- Baumgartner H, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38(21):2739-2791.